Keebeck Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Sell |
823
-59
| -7% | -$23.9K | 0.04% | 267 |
|
|
2025
Q1 | $439K | Buy |
882
+7
| +0.8% | +$3.49K | 0.06% | 180 |
|
|
2024
Q4 | $456K | Buy |
875
+42
| +5% | +$21.9K | 0.07% | 171 |
|
|
2024
Q3 | $516K | Buy |
833
+2
| +0.2% | +$1.24K | 0.07% | 166 |
|
|
2024
Q2 | $460K | Sell |
831
-115
| -12% | -$63.6K | 0.07% | 180 |
|
|
2024
Q1 | $550K | Sell |
946
-13
| -1% | -$7.56K | 0.08% | 178 |
|
|
2023
Q4 | $509K | Buy |
959
+13
| +1% | +$6.91K | 0.08% | 176 |
|
|
2023
Q3 | $479K | Hold |
946
| – | – | 0.08% | 178 |
|
|
2023
Q2 | $494K | Hold |
946
| – | – | 0.07% | 182 |
|
|
2023
Q1 | $546K | Hold |
946
| – | – | 0.09% | 154 |
|
|
2022
Q4 | $521K | Buy |
946
+14
| +2% | +$7.71K | 0.09% | 151 |
|
|
2022
Q3 | $473K | Hold |
932
| – | – | 0.09% | 155 |
|
|
2022
Q2 | $507K | Buy |
932
+135
| +17% | +$73.4K | 0.1% | 153 |
|
|
2022
Q1 | $471K | Hold |
797
| – | – | 0.08% | 166 |
|
|
2021
Q4 | $532K | Hold |
797
| – | – | 0.09% | 145 |
|
|
2021
Q3 | $456K | Hold |
797
| – | – | 0.09% | 143 |
|
|
2021
Q2 | $402K | Hold |
797
| – | – | 0.06% | 185 |
|
|
2021
Q1 | $364K | Hold |
797
| – | – | 0.06% | 183 |
|
|
2020
Q4 | $371K | Hold |
797
| – | – | 0.06% | 165 |
|
|
2020
Q3 | $352K | Buy |
797
+54
| +7% | +$23.8K | 0.07% | 147 |
|
|
2020
Q2 | $269K | Hold |
743
| – | – | 0.09% | 146 |
|
|
2020
Q1 | $210K | Hold |
743
| – | – | 0.09% | 136 |
|
|
2019
Q4 | $241K | Buy |
+743
| New | +$241K | 0.08% | 131 |
|